Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumor × enfortumab vedotin × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 14 Urinary Bladder Neoplasms 8 Ureteral Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Advanced Bladder Cancer 2 Urogenital Neoplasms 1 Urethral Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Peripheral Nervous System Diseases 1 Penile Squamous Cell Carcinoma (PSCC) 1 Muscle-invasive Bladder Cancer 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Metastatic Urothelial Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

tislelizumab 6 Injections 6 pembrolizumab 3 Nivolumab 3 toripalimab 2 Bevacizumab 2 zimberelimab 1 olaparib 1 erdafitinib 1 durvalumab 1 cemiplimab 1 avelumab 1 atezolizumab 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1 Drug Therapy 1 CD3 Complex 1 BID protein, human 1 Appointments and Schedules 1 Antineoplastic Agents 1 APG-1387 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡